Russian-Finnish Life Science Park
Large scale project of the South-East Finland-Russia CBC 2014-2020 Programme
About the project
The project of the South-East Finland-Russia CBC 2014-2020 programme
Project number: KS1444
The project is funded by the European Union, the Russian Federation and the Republic of Finland.
To contribute to the economic development and global competitiveness of Finland and Russia by positing the cross-border region as an emerging life science destination by establishment of cross-border life science parks as well as by strengthening internationalization of SMEs by fostering technology transfer and R&D cooperation including reboot of cooperation ties between academia and authorities
To position cross-border region as an emerging life science destination.
Key facts
- Consortium: Saint Petersburg Technopark (RUS) (Lead partner) and Municipality of the city of Kotka (FIN)
- Dates: 2019-2022
- Total budget: 3 500 000 Euro (programme funding: 2 800 000 Euro and co-financing: 700 000 Euro)
- Financing: the project is funded by the European Union, the Russian Federation and the Republic of Finland in the framework of South-East Finland-Russia CBC 2014-2020 programme.
Objectives
- To develop modern life science research and production capacities by establishing cutting-edge research and industrial life science park
- To foster SME innovation, joint R&D, internationalization and cross-border technology transfer by creating valued added partnerships between SMEs and other actors of triple helix model
- To establish, strengthen and promote new cross-border Russian-Finnish Life Science Cluster
- To enhance competitiveness and promote cross-border region as a emerging life science destination by creating and launching targeted integrated promo activities
- To reboot of the cooperation and to re-establish the ties between triple helix actors – SMEs, universities & academia as well as regional authorities.
- To create cross-border R&D teams composed of leading Russian and Finnish Scientists for the development and implementation of advanced synthesis technologies as well as to develop and pilot new cross-border curricula in the sphere of life science
Beneficiaries and target groups
- SMEs – developers and producers of pharma, biotech and food technologies and products
- Academia and R&D organizations
- Pharma, biotech and food clusters
- Federal and regional authorities
- SME and export support infrastructure
- Young talents and professional getting new opportunities for professional development